ST3GAL1 and breast carcinoma: Given our conflicting in vivo and in vitro cell behaviour studies alongside previous studies suggesting that ST3Gal1-associated sialylation promotes tumour immune evasion in breast cancer, we hypothesised that St3gal1-null cells failed to engraft in immunocompetent mice as a result of immune clearance45.